Biotechnology company ZandCell LLC reported on Tuesday the availability of a fast, reliable and affordable COVID-19 saliva based rapid antigen test kit to be used in airports, governments, states, hospitals, sports events and for healthcare workers.
According to ZandCell, its COVID-19 Rapid Antigen Test rapidly tests to qualitatively detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with high accuracy.
The saliva-based ZandCell COVID-19 Rapid Antigen Test is now available in large quantities and can quickly and effectively test patients for the infectious virus and provide immediate results within three to ten minutes.
ZandCell COVID-19 Rapid Antigen Test was CE certified on 11 September and will be available in the US upon EUA FDA approval.
Spinogenix reports approval of 'tazbentetol' as non-proprietary name for SPG302
Polarean expands XENOVIEW 3T Coil access with Philips compatibility
Immedica gets UAE approval for Zepzelca maintenance treatment
AstraZeneca to invest USD2bn in major Maryland manufacturing expansion
Nuvalent's zidesamtinib NDA filing accepted by US FDA
BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU